Galectin Therapeutics (GALT) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.20% |
| Dec 31, 2025 | -7.98% |
| Sep 30, 2025 | -17.69% |
| Jun 30, 2025 | -17.70% |
| Mar 31, 2025 | -26.40% |
| Dec 31, 2024 | -18.44% |
| Sep 30, 2024 | -10.61% |
| Jun 30, 2024 | -12.20% |
| Mar 31, 2024 | 27.02% |
| Dec 31, 2023 | 25.64% |
| Sep 30, 2023 | 15.86% |
| Jun 30, 2023 | 12.37% |
| Mar 31, 2023 | 32.61% |
| Dec 31, 2022 | 38.60% |
| Sep 30, 2022 | 20.64% |
| Jun 30, 2022 | 22.64% |
| Mar 31, 2022 | 19.15% |
| Dec 31, 2021 | 21.50% |
| Sep 30, 2021 | 18.74% |
| Jun 30, 2021 | 12.86% |
| Mar 31, 2021 | 0.10% |
| Dec 31, 2020 | 2.31% |
| Sep 30, 2020 | 9.62% |
| Jun 30, 2020 | 9.14% |
| Mar 31, 2020 | 8.03% |
| Dec 31, 2019 | 10.31% |
| Sep 30, 2019 | 10.14% |
| Jun 30, 2019 | 8.91% |
| Mar 31, 2019 | -26.66% |
| Dec 31, 2018 | -3.41% |
| Sep 30, 2018 | 1.66% |
| Jun 30, 2018 | 16.49% |
| Mar 31, 2018 | -7.28% |
| Dec 31, 2017 | -15.33% |
| Sep 30, 2017 | -8.93% |
| Jun 30, 2017 | -6.88% |
| Mar 31, 2017 | -2.07% |
| Dec 31, 2016 | 19.02% |
| Sep 30, 2016 | 14.74% |
| Jun 30, 2016 | 17.46% |
| Dec 31, 2015 | 33.19% |